COVID-19 drug trails | Preliminary trial results expected by summer
COVID-19 drug trails | Preliminary trial results expected by summer
COVID-19 drug trails | Preliminary trial results expected by summer | Coronavirus Pandemic |
well first up on the show the novel
coronavirus has so far infected more
than 1.9 million people worldwide and
resulting in the death
of close to lack 20 000 people but
a safe and effective vaccine for it is
still at least a year away however
researchers are rushing to well
repurpose existing drugs and non-drug
therapies as well as testing
promising experimental drugs that were
already in clinical trials to treat
covid19
let's take a look at some of the
important drugs that are being tested
remember as well this drug was
originally made to tackle the
rna virus as of now it is considered to
be the most promising against kovid 19
results from the trial i expected
in three months hydroxychloroquine
this is an anti-malaria drug also
believed to be antiviral
in one small french study some kovid 19
patients showed improvements but
there was no proof that the drug was the
reason
two other studies done in france and
china showed no benefit of the drug in
covet-19 treatment
india united states are using however
this drug currently as treatment for
covet-19 in some cases
dozens of clinical studies are underway
around the world
trial results are expected in three
months as well
now actima used for treating
arthritis and hyperimmune response in
cancer patients
15 registered trials are taking place in
china europe and the us
are testing it on cover 19 patients
alone or income in comparison to other
therapies
as well now cavezara is a
monoclonal antibody approved
for inflammatory arthritis and the drug
is targeting uh the immune response in
severely ill covenanting patients
results
here as well i expected in three months
now java key which has been developed to
treat
again inflammatory and autoimmune
diseases
one trial each in canada and mexico will
test the drug in copenhagen patients
with severe respiratory symptoms with
initial results expected by june
2020 so we are far away from actual
actually
using these vaccines on a wide scale
now caletra is again an antiviral
combination used to treat
and prevent hiv infections more than 20
trials around the world are underway and
initial results here
are expected by may 2020.
now let's take a look at
coronavirus has so far infected more
than 1.9 million people worldwide and
resulting in the death
of close to lack 20 000 people but
a safe and effective vaccine for it is
still at least a year away however
researchers are rushing to well
repurpose existing drugs and non-drug
therapies as well as testing
promising experimental drugs that were
already in clinical trials to treat
covid19
let's take a look at some of the
important drugs that are being tested
remember as well this drug was
originally made to tackle the
rna virus as of now it is considered to
be the most promising against kovid 19
results from the trial i expected
in three months hydroxychloroquine
this is an anti-malaria drug also
believed to be antiviral
in one small french study some kovid 19
patients showed improvements but
there was no proof that the drug was the
reason
two other studies done in france and
china showed no benefit of the drug in
covet-19 treatment
india united states are using however
this drug currently as treatment for
covet-19 in some cases
dozens of clinical studies are underway
around the world
trial results are expected in three
months as well
now actima used for treating
arthritis and hyperimmune response in
cancer patients
15 registered trials are taking place in
china europe and the us
are testing it on cover 19 patients
alone or income in comparison to other
therapies
as well now cavezara is a
monoclonal antibody approved
for inflammatory arthritis and the drug
is targeting uh the immune response in
severely ill covenanting patients
results
here as well i expected in three months
now java key which has been developed to
treat
again inflammatory and autoimmune
diseases
one trial each in canada and mexico will
test the drug in copenhagen patients
with severe respiratory symptoms with
initial results expected by june
2020 so we are far away from actual
actually
using these vaccines on a wide scale
now caletra is again an antiviral
combination used to treat
and prevent hiv infections more than 20
trials around the world are underway and
initial results here
are expected by may 2020.
now let's take a look at
Comments
Post a Comment